Literature DB >> 18631876

Expanding criteria for living kidney donors: what are the limits?

Stephen Textor1, Sandra Taler.   

Abstract

The need to evaluate potential living kidney donors is more pressing than ever before. Evaluating the potential medical risks to individual donors presents both medical and ethical questions related to quantitative hazards of donor nephrectomy. These include conditions commonly associated with age, such as the decline in glomerular filtration rate, the rise in arterial pressures, and weight gain. The "normal" ranges for many of these characteristics are changing as their importance as predictors of cardiovascular risk is reevaluated and the duration of exposure for a lifetime is considered. Many older donors in good health favor donating a kidney to a spouse, despite the presence of elevated blood pressure or even impaired glucose tolerance. The Mayo Kidney/Pancreas transplant program established an "extended criteria workgroup" to address these issues on an individual basis. Our program now stratifies medical criteria based upon age, allowing more liberal criteria for older donors. As a result, we accept treated hypertension in white donors, emphasizing the importance of informed consent and the need for vigilant follow-up. Our greatest concern relates to the development of obesity, particularly in younger individuals. Many of the long-term results of kidney donation are likely to hinge upon future behavior, including smoking, weight management, and medical follow-up care. Older donors are more likely to have established behavior patterns, an element that makes them better candidates in many respects. Studies to closely track the impact of donor nephrectomy in the current era with changing population demographics and expectations are essential.

Entities:  

Mesh:

Year:  2008        PMID: 18631876     DOI: 10.1016/j.trre.2008.04.005

Source DB:  PubMed          Journal:  Transplant Rev (Orlando)        ISSN: 0955-470X            Impact factor:   3.943


  5 in total

1.  Access to kidney transplantation among the elderly in the United States: a glass half full, not half empty.

Authors:  Elke S Schaeffner; Caren Rose; John S Gill
Journal:  Clin J Am Soc Nephrol       Date:  2010-10-28       Impact factor: 8.237

2.  Long-term renal function and cardiovascular disease risk in obese kidney donors.

Authors:  Mohammad M Tavakol; Flavio G Vincenti; Hamid Assadi; Michael J Frederick; Stephen J Tomlanovich; John P Roberts; Andrew M Posselt
Journal:  Clin J Am Soc Nephrol       Date:  2009-05-14       Impact factor: 8.237

3.  Latent abnormal pathology affects long-term graft function in elder living renal allograft recipients.

Authors:  Linlin Ma; Lei Zhang; Yu Du; Zelin Xie; Yawang Tang; Jun Lin; Wen Sun; Hongbo Guo; Rumei Bi; Mengmeng Zhang; Xi Zhu; Ye Tian
Journal:  Clin Dev Immunol       Date:  2013-09-19

4.  Medically Complex Living Kidney Donors: Where Are We Now?

Authors:  Stephen C Textor
Journal:  Kidney Int Rep       Date:  2019-11-13

Review 5.  Renal transplantation from elderly living donors.

Authors:  Jacob A Akoh; Umasankar Mathuram Thiyagarajan
Journal:  J Transplant       Date:  2013-09-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.